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The trans-well coculture of human synovial
mesenchymal stem cells with chondrocytes
leads to self-organization, chondrogenic
differentiation, and secretion of TGFβ
Eva Johanna Kubosch1, Emanuel Heidt1, Anke Bernstein1, Katharina Böttiger1 and Hagen Schmal2,3*
Abstract
Background: Synovial mesenchymal stem cells (SMSC) possess a high chondrogenic differentiation potential,
which possibly supports natural and surgically induced healing of cartilage lesions. We hypothesized enhanced
chondrogenesis of SMSC caused by the vicinity of chondrocytes (CHDR).
Methods: Human SMSC and CHDR interactions were investigated in an in-vitro trans-well monolayer coculture over
a time period of up to 21 days. Protein expression was analyzed using histology, immunostaining, or enzyme-linked
immunosorbent assay. Additionally, mRNA expression was assessed by quantitative PCR.
Results: After 7 days, phase-contrast microscopy revealed cell aggregation of SMSC in coculture with CHDR.
Afterwards, cells formed spheres and lost adherence. However, this phenomenon was not observed when culturing
SMSC alone. Fluorescence labeling showed concurrent collagen type II expression. Addition of transforming growth
factor beta (TGFβ) to the cocultures induced SMSC aggregation in less time and with higher intensity. Additionally,
alcian blue staining demonstrated enhanced glycosaminoglycan expression around SMSC aggregates after 1 and 2
weeks. Although TGFβ mRNA was expressed in all SMSC, the protein was measured with constantly increasing
levels over 21 days only in supernatants of the cocultures. Considering the enhanced mRNA levels following
supplementation with TGFβ, a positive feedback mechanism can be supposed. In line with the development of a
chondrogenic phenotype, aggrecan mRNA expression increased after 7 and 14 days in the cocultures with and
without TGFβ. Coculture conditions also amplified collagen type II mRNA expression after 2 weeks without and
already after 1 week with TGFβ. There was no difference in collagen type I and type X expression between SMSC
alone and the coculture with CHDR. Expression of both collagens increased following addition of TGFβ. mRNA data
correlated with the intensity of immunofluorescence staining.
Conclusions: Paracrine effects of CHDR induce a chondrogenic phenotype in SMSC possibly mimicking joint
homeostasis. Coculture approaches may lead to a better understanding of cellular interactions with potential
implications for cartilage repair procedures.
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Background
Cartilage lesions have a limited capacity for repair and
cause osteoarthritis (OA), so the search for treatment al-
ternatives is ongoing. Many current approaches focus on
the use of mesenchymal stem cells, which may play a
significant role in both natural and surgically supported
cartilage repair. Previously it has been described that
natural cartilage repair can occur, especially in osteo-
chondral defects; however, “the repair was mediated
wholly by the proliferation and differentiation of mesen-
chymal cells of the marrow” [1]. More recently, a pos-
sible role for synovial mesenchymal stem cells (SMSC)
was highlighted [2]. Injection of bone marrow-derived
mesenchymal stem cells (BMSC) in osteoarthritic knees
resulted in a long-term improvement of clinical outcome
parameters [3], and SMSC were successfully used for
arthroscopically assisted cartilage repair resulting in im-
proved MRI features, histology, and clinical outcome [4].
Different studies suggested that SMSC have the best
chondrogenic potential compared with mesenchymal
stem cells derived from other tissue sources [5]. Adher-
ence of SMSC to cartilage was mediated by hyaluronan
[6], a possible mechanism for how these cells may be
enriched in cartilage lesions. When SMSC migrate or
are surgically placed at the site of a cartilage defect, they
are in the direct vicinity of chondrocytes (CHDR) in
their natural habitat. For this specific situation, coculture
models are a powerful instrument to define and clarify
cell–cell interactions. Until now the emphasis of SMSC/
CHDR cocultures was to show effects in acute [7] or
chronic [8] inflammation. Hereby, it could be demon-
strated that SMSC were able to secret typical cartilage
markers such as aggrecan and decisively influence the
course of inflammation. Furthermore, pellet cocultures
of mesenchymal stem cells, usually bone marrow de-
rived, and CHDR resulted in formation of hyaline struc-
tured cartilage showing partially an even higher quality
than the CHDR control group [9]. This phenomenon
was independent of certain culture conditions and cell
sources [10]. The disadvantage of this experimental ap-
proach is the missing possibility to differentiate between
paracrine effects and cell–cell interactions. The hypoth-
esis of the study was that CHDR are able to induce a
chondrogenic differentiation of synovial stem cells. Since
we presumed paracrine signals originating from CHDR
causing this phenomenon, a coculture model was chosen
where the cells were separated by a filter. This model
does not allow direct cell contact and mimics the bio-
logical situation of cells collecting in a lesion with only
marginal contact to the original cartilage layer. For
evaluation, the markers of chondrogenesis aggrecan and
collagen type II, the marker of dedifferentiation collagen
type I, and the hypertrophy marker collagen type X were
analyzed on RNA and protein levels. Emphasis of the
study was the histological observation of cell organization,
the time frame, and the influencing cytokines.
Methods
Isolation, culture, and importance of SMSC in inflamma-
tion have been described previously [7]. The cells’ prepar-
ation protocols were approved by the Ethics Committee of
the University of Freiburg as part of the “Tissue Bank for
Research in the Field of Tissue Engineering” project
(GTE-2002) and the biobank “Osteo” (AN-EK-FRBRG-
135/14). Cells from the same donors were used when
comparing different culture conditions.
Isolation of SMSC
The cell preparation was described before [7]. Briefly,
synovial tissue was gathered during knee operations with
arthrotomy and arthroscopies (n = 4, male/female 2/2,
average age 42.7 ± 15.0 years). The degree of OA was
evaluated on X-ray images using Croft’s modification of
the Kellgren and Lawrence score (KLS). Cells were used
only from patients with healthy joints (KLS ≤ 2). The
harvested tissue was kept in DMEM F-12 medium
(Lonza BioWhittaker, Basel, Switzerland) at 4 °C. Within
2 h the tissue was cut into small pieces, washed, and
transferred into DMEM F-12 medium with 10 % FCS
(Biochrom, Berlin, Germany), 1 % penicillin/strepto-
mycin (P/S) (Invitrogen, Karlsruhe, Germany), 0.5 %
gentamycin (Biochrom), and 3 % collagenase P (Roche,
Mannheim, Germany). The suspension was digested
during the next 4 h on a shaking incubator (200 rpm) at
37 °C. Subsequently the released cells were centrifuged,
washed, and seeded in expansion medium DMEM F-12
(10 % FCS, 1 % P/S, 0.5 % gentamycin). SMSC were
seeded on coated T-flasks with a density of 2500–5000
cells/cm2 for expansion. The cells were frozen after
reaching confluence. Thawed cells were grown and used
when reaching a log phase of growth (passage 1). These
cells were not further enriched and are also known as
synovial fibroblasts or type B synoviocytes [11, 12].
Characterization of these cells was done by FACS
showing that combined expression of the stem cell
markers CD44, CD73, CD90, and CD105 was present
in 76 %, but the combined expression of the negative
markers CD11b, CD19, CD34, CD45, and HLA-DR
reached only 6.9 ± 1.7 %. Osteogenic, adipogenic, and
chondrogenic differentiation was possible using stand-
ard protocols [13].
Isolation of CHDR
Cell preparation was described before [14]. Briefly,
CHDR were gained from femoral heads during hip
arthroplasty operations (n = 6, male/female 5/1, average
age 79.2 ± 8.2 years). The degree of OA was evaluated
on X-ray images using Croft’s modification of the KLS
Kubosch et al. Stem Cell Research & Therapy  (2016) 7:64 Page 2 of 11
score. Cells from patients with advanced OA (≥ grade 3)
were not used for experiments. Within 8 h after surgery,
the cartilage was separated from the bone and cut into
small pieces, washed, and transferred into DMEM F-12
10 % FCS, 1 % P/S, 0.5 % gentamycin, and 3 % collage-
nase CLS type II (Biochrom). Minced cartilaginous tissue
was then enzymatically digested during the next 16 h on a
shaking incubator at 37 °C with 200 rpm. Subsequently the
released CHDR were centrifuged, washed, and seeded in
expansion medium DMEM F-12 (Lonza BioWhittaker) (10
% FCS, 1 % P/S, 0.5 % gentamycin). Expansion of CHDR
was performed by seeding them on coated T-flasks with a
density of 2500–5000 cells/cm2. The cells were frozen after
reaching confluence. Thawed cells were grown and used
when reaching a log phase of growth (passage 1).
Coculture conditions
SMSC in the bottom and CHDR on top were separated
in a trans-well culture with 0.4 μm inserts. As a basal
culture medium, DMEM F-12 medium supplemented
with 10 % FCS, 1 % P/S, and 0.5 % gentamycin was used.
Cell viability was >95 % before starting the experiment.
Half-media changes were performed three times per
week. The initial seeding density was 20,000 cells/cm2.
Experiments were repeated at least three times with cells
from different donors (one patient for one experimental
trial). The cells were not pooled. The total time of cocul-
ture was 21 days maximum. There were three different
groups: SMSC alone, SMSC with CHDR, and SMSC
with CHDR supplemented with transforming growth
factor beta (TGFβ)-3. A concentration of 10 ng/ml TGF-
β3 (R&D Systems, Minneapolis, MN, USA) was added
to the positive controls.
TGFβ enzyme-linked immunosorbent assay
TGFβ levels in supernatants were analyzed by enzyme-
linked immunosorbent assay (ELISA) (R&D; and Bio-
Source Deutschland GmbH, Solingen, Germany) accord-
ing to the manufacturers’ instructions. Briefly, this assay
employs the quantitative sandwich enzyme immunoassay
technique. The microplate was precoated with a specific
monoclonal antibody. Supernatants were applied to the
wells and, after washing, HRP-conjugated specific anti-
body was added to the wells. Following the next wash,
color development was proportional to the protein con-
centration and calculated by comparison with a stand-
ard. A colorimetric method was applied to quantify the
total protein amount in the lavage fluids.
Histology
Cover slides were coated with poly-D-lysine (0.1 mg/ml)
(Merck Millipore, Billerica, Massachusetts, USA) at 37 °C
(5 % CO2) for 60 min, then washed and dried overnight.
Afterwards, SMSC were grown on the slides in coculture
in 24-well-plates (Corning Incorporated, Corning, NY,
USA). For alcian blue staining, the cells were fixed and
stained using the PAS-staining Kit (Merck Millipore,
Billerica, Massachusetts, USA). Briefly, staining with
alcian blue was followed by incubation with periodic
acid, Schiff reagent, and hematoxylin, whereupon each
step was followed by washing. After mounting, histo-
logical pictures were analyzed using an Olympus BX51
microscope (Olympus Deutschland GmbH, Hamburg,
Germany) with the software module Stream Motion
adjusting only brightness and contrast.
Immunohistology
Cells were fixed at –20 °C with methanol (Sigma-Aldrich,
St. Louis, MO, USA) for 10 min; afterwards, they were
washed with Dulbecco’s phosphate-buffered saline (DPBS;
Gibco Invitrogen, Carlsbad, CA, USA). For blocking
of unspecific binding sites, cells were incubated at
room temperature with 5 % BSA (AppliChem GmbH,
Darmstadt, Germany) in DPBS. Primary antibodies were
diluted as follows: collagen type I (mouse monoclonalAb
COL-1; abcam, Cambridge, UK) 1:500, collagen type II
(rabbit polyclonalAb COL-2; abcam) 1:250, and collagen
type X (mouse monoclonalAb COL-10; abcam) 1:750.
After washing, the antibody working solutions were applied
to the cells and incubated at 4 °C overnight in a humid
chamber. After washing three times, the cells were incu-
bated with the working solution of the secondary antibody:
Alexa Fluor 488 goat anti-mouse IgG and Alexa Fluor 568
goat anti-rabbit IgG (Life Technologies, Grand Island, NY,
USA) in 1 % BSA, dilution 1:250. After washing three times
again, color reagent (ProLong® Gold antifade reagent DAPI;
Life Technologies) was applied. An Olympus BX51 micro-
scope (Olympus Deutschland GmbH) with special fluores-
cence filters was used for image acquisition. The program
ImageJ (Wayne Rasband, NIH; imagej.nih.gov/ij/download)
facilitated overlaying of images.
Real-time PCR
Real-time PCR was carried out for SMSC only. RNA sam-
ples from days 7 and 14 were transcribed into cDNA;
RNA analysis was carried out for gene expression of
aggrecan, TGFβ, and collagen type I, II, and X. Total
mRNA was prepared using the Qiagen RNeasy kit accord-
ing to the manufacturer’s instructions (Qiagen, Hilden,
Germany). Total RNA (1 μg) was treated with 1 U DNAse
I (Invitrogen, Karlsruhe, Germany) to remove genomic
DNA. Poly-T primed cDNA synthesis was performed
using 1 U reverse transcriptase III (RTIII; Invitrogen) per
1 μg RNA according to the manufacturer’s instruc-
tions. TaqMan™ PCR assays were performed in 384-
well plates in a Roche LightCycler480 (Roche) using
the Roche LightCycler Mastermix. For gene expres-
sion analyses, Roche’s universal ProbeLibrary Probes
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and recommended Universal ProbeLibrary Reference
Gene Assays were used. The cycling conditions were de-
naturation (one cycle: 50 °C for 120 sec, 95 °C for 600
sec), followed by 40 amplification cycles (95 °C for 15 sec,
60 °C for 60 sec, 72 °C for 10 sec), followed by melting
(one cycle: 95 °C for 10 sec, 50 °C for 30 sec, 70 °C for 1
sec), and cooling (one cycle: 40 °C for 30 sec). Data were
quantified via ΔΔCT comparisons. Data were normalized
by comparing genes of interest versus reference genes
(GAPDH). Reaction efficiency is controlled by a relative
standard curve and/or a calibrator per reaction. Real-time
PCR was carried out in quadruplicate, each value repre-
senting an average of four experiments.
Data analysis and statistics
Concentrations of cytokines determined by the specific
ELISA were calculated according to the manufacturers’
instructions (R&D; and Thermo Scientific, Rockford, IL,
USA), creating a standard curve and reducing data with
a four-parameter logistic (4-PL) curve fit using Graph-
Pad Prism 5 software (GraphPad Software, Inc., La Jolla,
CA, USA). All values were expressed as mean ± standard
error of the mean. Statistical significance was tested
nonparametrically using the Mann–Whitney U test. The
values of different time points were compared in each
group, and the values of one time point were compared
between the groups. Statistical significance was defined
as p < 0.05.
Results
Histology
SMSC were kept in monolayer cultures alone or in co-
culture with CHDR. As a positive control, these cocul-
tures were supplemented with TGFβ. While SMSC alone
stayed separated after 1 week, an aggregation of SMSC
was visible in the coculture group. The addition of TGFβ
even resulted in sphere formation (Fig. 1a–c). No further
time points are shown, because the spheres lost adher-
ence and could no longer be comparably stained. Since
spin-downs resulted in cell debris, SMSC were grown on
coated cover slides allowing only alcian blue staining
and phase-contrast microscopy as shown in Fig. 1d.
Again, the phenomenon of cell aggregation, sphere for-
mation, and loss of adherence could be observed after 1
or 2 weeks, first in the TGFβ-treated positive control
and then in the coculture. The alcian blue staining,
which was more intense in cell aggregates, documents
the presence of glycosaminoglycans/mucopolysaccha-
rides. Cell aggregation could be observed with the cells
of all different donors. Figure 1a compares the different
groups by overlaying immunofluorescence staining and
phase-contrast microscopy images. Figure 1b shows the
single staining for collagen type I and type II of the dif-
ferent groups. The highest intensity but also the highest
cell density was observed in the TGFβ-treated positive
control group. Figure 1c demonstrates representative
slides of the single staining for collagen type X and the
DAPI staining for the different groups. The percentage-
wise estimation of the aggregation extent was 0 % for
SMSC alone, ≥40 % for the coculture of SMSC with
CHDR, and ≥90 % for the coculture supplemented with
TGFβ (overview in phase-contrast microscopy). Addition-
ally, cell spheres per field of view were counted resulting
in 0 ± 0 aggregates/field for SMSC alone, 1 ± 0.4 aggre-
gates/field for the coculture of SMSC with CHDR, and
2.25 ± 0.5 aggregates/field for the coculture supplemented
with TGFβ (n = 5, 20-fold magnification). There was no
difference comparing the aggregation after 7 or 14 days.
Role for TGFβ
TGFβ concentrations in the supernatants were measured
comparing SMSC in monolayer with the coculture of
SMSC and CHDR without or with TGFβ supplementa-
tion (Fig. 2). As expected, the highest concentrations
were observed in the positive control with TGFβ (777 ±
28 pg/ml). This is lower than the added concentrations
indicating receptor immobilization of the cytokine or
degradation, because supernatants were collected to-
gether with medium change. Concentration levels are
followed by the coculture without TGFβ supplementa-
tion starting at week 1 with 68 ± 5 pg/ml and steadily in-
creasing up to 183 ± 15 pg/ml at week 3. Although
TGFβ was also found in the SMSC monolayer, levels
were short over the detection limit. There was a statisti-
cally significant difference between the levels of each
time point of all groups and each time point within the
cocultures (p < 0.05). Because the statistical significance
reached was marginal, additional comparisons were cal-
culated using a Student’s t test, resulting in p < 0.02. Fur-
thermore, the values of all groups were merged
independent of the time point. The comparison resulted
in highly significant differences (p < 0.001) using the dir-
ect comparison of groups with the Mann–Whitney U
test and using the Kruskall–Wallis H test (multiple com-
parisons). Considering a significance level of the direct
group comparisons very close to the defined α and a
possibly not complete random sample, the tests may
overstate the accuracy of the results. TGFβ mRNA ex-
pression was also compared over a 2-week interval
(Fig. 3). A statistically significant difference was found
between the TGFβ-supplemented group and both other
groups (p = 0.021), but not between the different time
points within each group.
mRNA regulation of aggrecan and collagen type I, II, and X
Aggrecan mRNA expression was compared in SMSC
monolayer with the coculture of SMSC and CHDR with-
out or with TGFβ supplementation (Fig. 4). The highest
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Fig. 1 (See legend on next page.)
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levels were found in both cocultures at both investigated
time points (without TGFβ: 4.7 ± 1.2-fold at week 1 and
6.7 ± 1.1-fold after 2 weeks, with TGFβ: 6.5 ± 0.9-fold at
week 1 and 4.9 ± 1.1-fold at week 2). There is a statisti-
cally significant difference between both cocultures and
the monolayer, but not between the different time points
within each group. Collagen type I (col1) mRNA expres-
sion was also compared between SMSC monolayer with
the coculture of SMSC and CHDR without or with sup-
plemented TGFβ (Fig. 5). The highest values were mea-
sured in the TGFβ-supplemented coculture (up to 1625
± 219-fold). There is a statistically significant difference
between the TGFβ-supplemented group and both other
groups (p = 0.021), but not between the different time
points within each group or SMSC alone and the non-
supplemented coculture. Collagen type II (col2) mRNA
expression was also examined (Fig. 6), showing the high-
est values in both cocultures (up to 8.9 ± 3.2-fold). There
was no statistically significant difference between the
TGFβ-supplemented group and day 14 of the coculture,
but these values were higher compared with SMSC
alone and day 7 of the coculture (p = 0.021). There is no
difference between the two time points within each
group except for the coculture without TGFβ. Here the
col2 mRNA increased between the first week and the
second week significantly (p = 0.043). Since collagen type
II is considered the main marker for differentiated cartil-
age, the results indicate increasing chondrogenic differ-
entiation induced by the presence of CHDR in coculture
and the addition of TGFβ. Furthermore, the mRNA of
the chondrogenic hypertrophy marker collagen type X
(col10) was analyzed (Fig. 7). Although we found signifi-
cant values at day 7 in the plain coculture, the highest
values were measured when TGFβ was supplemented
(up to 3.1 ± 0.7-fold). The value in the TGFβ-
supplemented group at day 7 is statistically significantly
higher than at all other time points (p = 0.014). There is
no difference between the different time points within
the SMSC (0 caused by rounding) and the coculture
groups.
Discussion
The main finding of the study is that human CHDR are
able to induce a chondrogenic phenotype in human
SMSC in a trans-well coculture. Although SMSC were
kept in a monolayer, chondrogenesis leads to loss of ad-
herence and formation of spheres. This was sufficiently
regulated by paracrine factors; no direct cell–cell
(See figure on previous page.)
Fig. 1 a Self-organization of SMSC after 7 days in monolayer culture. SMSC alone (left) stay separated, but in coculture with CHDR (middle) an
aggregation of cells is visible, and addition of TGFβ (right) results in sphere formation. Upper row shows overlaying immunofluorescence staining
(green: collagen type I, red: collagen type II, blue: DAPI; scale 20 μm), and lower row the phase-contrast microscopy. b Single staining for collagen
type I (upper row) and type II (lower row) of the different groups. c Single staining for collagen type X and DAPI of the different groups. d Alcian
blue (AB) staining of the different groups and time points. Upper row: AB 7 days (marker 50 μm), middle row: AB 14 days (marker 100 μm), lower
row: phase-contrast (PC) microscopy 14 days (marker 100 μm). CHDR chondrocytes, SMSC synovial mesenchymal stem cells, TGFβ transforming
growth factor beta (Color figure online)
Fig. 2 TGFβ concentrations in supernatants comparing SMSC in monolayer with the coculture of SMSC and CHDR without or with TGFβ
supplementation. There is a statistically significant difference between the groups and each time point within the cocultures. CHDR chondrocytes,
SMSC synovial mesenchymal stem cells or SFB synovial fibroblasts, TGFβ transforming growth factor beta
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interactions were necessary. The degree of cell self-
assembly and sphere formation and the collagen type II
and aggrecan expression were associated with the levels
of TGFβ found in the supernatants. Collagen type X, a
marker of chondrocyte hypertrophy, was expressed in
the coculture of SMSC and CHDR when TGFβ was
additionally supplemented.
Cocultures of mesenchymal stem cells and CHDR can
result in improved chondrogenic differentiation in pel-
lets [9] and immunological interactions including anti-
inflammatory regulations attributed to mesenchymal
stem cells [15]. The possible high impact of coculture sys-
tems on cartilage tissue engineering is documented by the
increasing number of described technical solutions [16]
and experimental designs [17]. In contrast to previous
studies, this investigation focused on an experimental
trans-well design using human synovial stem cells. This
set-up was inspired by the idea that—unlike the previously
suggested predominant role of bone marrow-derived pro-
genitor cells for cartilage regeneration [1]—synovial stem
Fig. 3 TGFβ mRNA expression comparing SMSC in monolayer with the coculture of SMSC and CHDR without or with TGFβ supplementation. There is
a statistically significant difference between the TGFβ-supplemented group and both other groups, but not between the different time points within
each group. CHDR chondrocytes, SMSC synovial mesenchymal stem cells or SFB synovial fibroblasts, TGFβ transforming growth factor beta
Fig. 4 Aggrecan mRNA expression comparing SMSC in monolayer with the coculture of SMSC and CHDR without or with TGFβ supplementation.
There is a statistically significant difference between both cocultures and the monolayer, but not between the different time points within each
group. CHDR chondrocytes, SMSC synovial mesenchymal stem cells or SFB synovial fibroblasts, TGFβ transforming growth factor beta
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cells might be able to contribute to natural cartilage re-
generation. This phenomenon has been described, but the
cellular sources for repair are controversially discussed.
The potential of CHDR themselves appears to be very lim-
ited, as previously published outgrowth experiments have
shown [18]. Since synovial fibroblasts are located in the
direct vicinity of cartilage and cartilage lesions and also
exhibit stem cell characteristics [19] with the best chon-
drogenic potential of different mesenchymal stem sources
[5], these cells are an interesting candidate for the cellular
origin of natural and spontaneous cartilage regeneration.
The natural environment of cells, especially stem cells, de-
termines their histological and biochemical phenotype
[20]. Therefore, we hypothesized that CHDR are able to
secret paracrine signals inducing a chondrogenic differen-
tiation of SMSC. This was confirmed by showing spontan-
eous formation of first cell aggregation and then cell
sphere formation by SMSC in coculture with CHDR. This
Fig. 5 Collagen type I (col1) mRNA expression comparing SMSC in monolayer with the coculture of SMSC and CHDR without or with TGFβ
supplementation. There is a statistically significant difference between the TGFβ-supplemented group and both other groups, but not
between the different time points within each group. CHDR chondrocytes, SMSC synovial mesenchymal stem cells or SFB synovial fibroblasts,
TGFβ transforming growth factor beta
Fig. 6 Collagen type II (col2) mRNA expression comparing SMSC in monolayer with the coculture of SMSC and CHDR without or with TGFβ
supplementation. There is no statistically significant difference between the TGFβ-supplemented group and day 14 of the coculture, but these values
are higher compared with SMSC alone and day 7 of the coculture. There is no difference between the different time points within each group except
for the coculture. CHDR chondrocytes, SMSC synovial mesenchymal stem cells or SFB synovial fibroblasts, TGFβ transforming growth factor beta
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was accompanied by expression of cartilage markers as
aggrecan and collagen type II on the protein and mRNA
levels. The key role for TGFβ in the described and ob-
served process of chondrogenic differentiation was not
only demonstrated for BMSC [21], but also for SMSC
[22]. TGFβ has been described to upregulate collagen type
I mRNA in osteoblasts [23] or CHDR [24]. Furthermore,
TGFβ seems to induce the cartilage hypertrophy marker
collagen type X. This was confirmed by our results, but
high levels of either collagen type I or type X were mainly
found in the control group that was supplemented with
additional TGFβ. In accordance with these data, the
hypertrophic status of chondrogenically differentiated
mesenchymal stem cells has previously been described to
be associated with overexpression of osteogenic markers
as collagen type I and alkaline phosphatase [25], explaining
our positive immunostaining and the higher collagen type
I mRNA expression in the TGFβ-supplemented group.
The fact that exogenous TGFβ supplementation up-
regulated collagen type I and type X in the SMSC with-
out providing further enhancement of collagen type II or
aggrecan expression is probably a dosage effect, assum-
ing that the CHDR are promoting chondrogenesis in
SMSC by releasing TGFβ; or it could suggest that CHDR
are releasing other paracrine factors modulating the ef-
fect. This has to be considered also in the light of the
only marginal statistical significance regarding the in-
creased TGFβ concentrations in the supernatants of the
coculture. However, the CHDR alone had a chondro-
genic effect (at least in terms of gene expression and
sphere formation), causing minimal fibrochondrogenesis
(col1) or hypertrophy (col10).
The observed missing accordance of TGFβ mRNA and
protein regulation in the supernatants can have different
causes. First, TGFβ protein might also significantly be
secreted by CHDR, which in the current experimental
set-up cannot be measured separately. Secondly, protein
formation in SMSC might undergo further regulatory
processing and not only depend on RNA regulation. The
higher levels of TGFβ mRNA in the supplemented co-
culture suggest a positive feedback regulation.
Chondrogenesis of SMSC was also demonstrated in a
pellet coculture model using rabbit CHDR that overex-
pressed TGFβ after adenoviral transfection [26]. Based
on the results of our study it may be concluded that
gene transfer might not be necessary, because the cocul-
ture itself provides sufficient paracrine stimuli for chon-
drogenic differentiation of SMSC. Similarly, TGFβ
induced the chondrogenesis of SMSC with high levels of
collagen type II, aggrecan, and Sox 9, and low levels of
dedifferentiation or hypertrophy markers in a coculture
pellet model using nucleus pulposus cells in serum-free
medium [27]. All of the data emphasize the key role for
TGFβ in chondrogenic differentiation for both in-vitro
cultures of mesenchymal stem cells of different origin
[13] and in the natural articular environment. Although
the role of TGFβ seems striking, there are a few limita-
tions attributed to the presented experimental set-up.
First, the measured TGFβ levels in the supernatants are
a summary response of all cells, which makes it
Fig. 7 Collagen type X (col10) mRNA expression comparing SMSC in monolayer with the coculture of SMSC and CHDR without or with TGFβ
supplementation. The value of the TGFβ-supplemented group at day 7 is statistically significantly higher than at all other time points. There is no
difference between the different time points within the SMSC and the coculture groups. CHDR chondrocytes, SMSC synovial mesenchymal stem
cells or SFB synovial fibroblasts, TGFβ transforming growth factor beta
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impossible to differentiate the true origin. This is the na-
ture of a coculture, and therefore mRNA levels were de-
termined in SMSC. Unfortunately, the data were not
completely conclusive, because TGFβ mRNA could also
be found in SMSC alone, indicating separate regulation
pathways for protein and mRNA. Secondly, the simple
presence of TGFβ does not allow drawing functional
conclusions. This means we observed an association of
TGFβ in the supernatant and chondrogenic differenti-
ation of SMSC, but the biological or mechanistic relation
is not necessarily evident. However, the stimulatory suc-
cess of the coculture with CHDR on the chondrogenic
differentiation of SMSC underlines the potential role of
these cells in natural and artificially supported cartilage
repair.
Conclusions
The vicinity of CHDR in a trans-well coculture induces
a chondrogenic phenotype in SMSC. This process is
associated with increased TGFβ secretion and offers
possible implications for cartilage repair. This effect
may play a significant role in natural and surgically in-
duced cartilage repair, especially in cell therapeutic
approaches.
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